Helping to improve clinical risk, reduce litigation risk and improve healthcare standards.

GA1 is an inherited metabolic disorder resulting from a deficiency of the enzyme glutaryl-CoA dehydrogenase and is genetically determined. Diagnosis of GA1 is imperative so as to ensure that a carefully controlled diet is implemented so as to prevent brain damage from occurring.

This clinical risk alert from our lead clinical partner, TMLEP, covers the risks of complications regarding Central venous pressure (CVP) lines. CVP lines are used to monitor central venous blood pressure. It is important that the risks and complications of CVP line insertion are explained to the patient to ensure they are correctly consented under Montgomery v Lanarkshire Health Board [2015] UKSC 11.

This clinical risk alert from our lead clinical partner, TMLEP, covers the complications of spinal fluid drainage in thoracoabdominal aortic aneurysm repair. Paraplegia is a devastating complication which may occur following surgery on the thoracic aorta. It is a result of interruption of the blood supply to the spinal cord.

This clinical risk alert from our lead clinical partner, TMLEP, explores the understanding behind the neurological complications of Sepsis. Sepsis can lead to a range of complications, most critically it is commonly fatal, particularly if the diagnosis is delayed, or in patients with other significant health problems.

This case study, by our lead clinical partner TMLEP, highlights that clinicians need to ensure patients are clearly aware of the pros and cons of undergoing surgery and any non-surgical alternatives available. It is imperative that the consultation is well-documented, legible, and truthfully reflects what was discussed before the patient consents to treatment.

This is a case, from our lead clinical partner, TMLEP, where a teenager presented with clinically significant and ominous features of an underlying infection that required urgent treatment.